Skip to content

Assembly Biosciences ASMB Shares (Diluted)

Shares (Diluted) at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
142.4M+5.9%
ALN
Alnylam PharmaceuticalsALNY
138.2M+6.6%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
20.1M+91.2%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
195.2M+2.4%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
147.4M+7.2%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
146.4M+2.1%

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's shares (diluted)?
Assembly Biosciences (ASMB) reported shares (diluted) of 16.9M in Q1 2026.
How has Assembly Biosciences's shares (diluted) changed year-over-year?
Assembly Biosciences's shares (diluted) increased by 125.1% year-over-year, from 7.5M to 16.9M.
What is the long-term trend for Assembly Biosciences's shares (diluted)?
Over 4 years (2021 to 2025), Assembly Biosciences's shares (diluted) has grown at a -30.9% compound annual growth rate (CAGR), from 171.4M to 39.1M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.